Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

The purpose of this study is to evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk

Age range

50 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Ajaccio, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults 50 years old and over, visiting their GPs

Treatment and study plan

Primary outcomes

To evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation (according to guidelines and validated scales (such as risk score profile in the Framingham Heart study or the SCORE risk estimation))

Time frame: At the end of the study

Secondary outcomes

To estimate the number of cardiovascular risk patients, that have not been identified

Time frame: At the end of the study
To characterize those patients according to their theoretical cardiovascular risk (high, medium, low)

Time frame: At the end of the study
to reveal GP's estimation of cardiovascular risk is especially driven by LDL

Time frame: At the end of the study

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Connection Between GP's Estimation of Cardiovascular Risk and Theoretical Calculation in France

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Dec 25, 2009
Registry last updated: Sep 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed